CollPlant Revenue and Competitors

Rehovot,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • CollPlant's estimated annual revenue is currently $12.9M per year.(i)
  • CollPlant's estimated revenue per employee is $155,000

Employee Data

  • CollPlant has 83 Employees.(i)
  • CollPlant grew their employee count by 2% last year.

CollPlant's People

NameTitleEmail/Phone
1
Personal Assistant to CEO and Deputy CEO, CollPlantReveal Email/Phone
2
Deputy CEO & Chief Financial OfficerReveal Email/Phone
3
VP Research And DevelopmentReveal Email/Phone
4
Head Analytical DevelopmentReveal Email/Phone
5
VP OperationsReveal Email/Phone
6
Head Process DevelopmentReveal Email/Phone
7
VP Regulatory Affairs and Quality AssuranceReveal Email/Phone
8
Head BioInk Research & DevelopmentReveal Email/Phone
9
Head Chemistry & Formulations DevelopmentReveal Email/Phone
10
Head Research - Regenerative Breast Implant ProgramReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is CollPlant?

CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing. Our revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes our rhCollagen the ideal building block for regenerative medicine. Leveraging on the unique properties of rhCollagen and biomaterial know-how, we are developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics. Our mission at CollPlant is to deliver ground-breaking products for regenerative medicine that offer the optimal treatment options to patients.

keywords:N/A

N/A

Total Funding

83

Number of Employees

$12.9M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CollPlant News

2022-04-17 - Short Interest in CollPlant Biotechnologies Ltd. (NASDAQ ...

Research analysts forecast that CollPlant Biotechnologies will post -0.38 earnings per share for the current fiscal year. A number of...

2022-04-13 - CollPlant To Present at the Aesthetics Innovation Summit 2022

CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics.

2022-03-22 - CollPlant Biotechnologies Provides Business Updates and ...

CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.9M838%$83M
#2
$13.5M874%N/A
#3
$35.1M10824%N/A
#4
$32.4M120-10%N/A
#5
$32.9M122-3%N/A